Trials / Conditions / Post Menopausal Osteoporosis

Post Menopausal Osteoporosis

27 registered clinical trials studyying Post Menopausal Osteoporosis — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Evaluation of Adherence With Bisphosphonates and Calcium and Vitamin D Supplements in Women With Postmenopausa NCT07105163	Procare Health Iberia S.L.	—
Recruiting	Study of the Impact of Mother-of-pearl Nutritional Supplementation on the Prevention of Post-menopausal Osteop NCT05571514	Centre Hospitalier Universitaire de Saint Etienne	N/A
Completed	Lactobacillus Acidophilus and Postmenopausal Women NCT05332626	Poznan University of Life Sciences	N/A
Completed	A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteopo NCT03432533	Amgen	Phase 3
Completed	Characteristics and Management of Postmenopausal Women With Osteoporosis Treated With Prolia® in France NCT02347865	Amgen	—
Unknown	Vitamin K as Additive Treatment in Osteoporosis NCT01232647	Guy's and St Thomas' NHS Foundation Trust	Phase 2 / Phase 3
Withdrawn	Bone Healing in Healthy and Post-menopausal Osteoporotic Women NCT01826656	University College, London	N/A
Completed	Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Ost NCT01732770	Amgen	Phase 4
Completed	Phase 2 Study of BA058 (Abaloparatide) Transdermal Delivery in Postmenopausal Women With Osteoporosis NCT01674621	Radius Health, Inc.	Phase 2
Completed	A Study of Bonviva/Boniva (Ibandronate) in Biphosphonate-Naïve Women With Post-Menopausal Osteoporosis NCT01290094	Hoffmann-La Roche	Phase 3
Completed	Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Doses of PTH134 in Post-menopausal Women NCT01224717	Novartis	Phase 1
Completed	Intra-venous Zoledronic Acid Once Yearly NCT00984893	Novartis Pharmaceuticals	—
Completed	3 yr Efficacy & Safety Study of Zoledronic Acid in Post-menopausal Women With Osteoporosis Treated With Zol Ac NCT00718861	Novartis Pharmaceuticals	Phase 3
Completed	A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis a NCT00503113	Hoffmann-La Roche	Phase 4
Completed	Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential Effects NCT00666627	Sheffield Teaching Hospitals NHS Foundation Trust	Phase 2
Completed	BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosp NCT00545779	Hoffmann-La Roche	Phase 3
Completed	ExBonAdAsia Study: A Study of Once Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis. NCT00545090	Hoffmann-La Roche	Phase 4
Completed	SUMMIT Study: A Study of Persistence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteo NCT00545480	Hoffmann-La Roche	Phase 4
Completed	A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporos NCT00377234	Hoffmann-La Roche	Phase 4
Completed	A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Iband NCT00303485	Hoffmann-La Roche	Phase 4
Completed	A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Who Have Received Previous Bonviva NCT00551174	Hoffmann-La Roche	Phase 4
Completed	A Study of Ibandronate (Boniva) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Postmenopausal NCT02598934	Hoffmann-La Roche	Phase 4
Completed	A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva NCT00081653	Hoffmann-La Roche	Phase 4
Completed	DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women Wit NCT00048074	Hoffmann-La Roche	Phase 3
Completed	MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis NCT00048061	Hoffmann-La Roche	Phase 3
Completed	Vitamin K Supplementation in Post-Menopausal Osteopenia NCT00150969	University Health Network, Toronto	Phase 3
Completed	Proof of Concept (Bone Resorption/Bone Mineral Density) Study (0429-005) NCT00533650	Merck Sharp & Dohme LLC	Phase 2